0001209191-20-010479.txt : 20200219
0001209191-20-010479.hdr.sgml : 20200219
20200219160303
ACCESSION NUMBER: 0001209191-20-010479
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Becker Marc A.
CENTRAL INDEX KEY: 0001618060
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 20629609
MAIL ADDRESS:
STREET 1: 175 CROSSING BLVD.
STREET 2: 4TH FLOOR
CITY: FRAMINGHAM
STATE: MA
ZIP: 01702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-14
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001618060
Becker Marc A.
C/O CONCERT PHARMACEUTICALS, INC.
65 HAYDEN AVENUE, SUITE 3000N
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Common Stock
2020-02-14
4
A
0
28216
A
56309
D
Stock Option (Right to Buy)
10.87
2020-02-14
4
A
0
42430
0.00
A
2030-02-13
Common Stock
42430
42430
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of the Issuer.
The RSUs granted to Mr. Becker will vest in three equal annual installments measured from the date of grant. The number above represents the maximum number of shares that may be delivered pursuant to the award.
Not applicable.
The shares underlying this option vest in equal quarterly installments over a four-year period measured from the date of grant.
/s/ Marc A. Becker
2020-02-19